• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fast reliable assay for morphine and its metabolites using high-performance liquid chromatography and native fluorescence detection.

作者信息

Venn R F, Michalkiewicz A

机构信息

Pain Research Institute, Liverpool, U.K.

出版信息

J Chromatogr. 1990 Feb 23;525(2):379-88. doi: 10.1016/s0378-4347(00)83414-3.

DOI:10.1016/s0378-4347(00)83414-3
PMID:2329165
Abstract

A method for the fast analysis of morphine (M), normorphine (NM), morphine-3- and -6-glucuronides (M3G and M6G) and codeine (C) is described which has the advantages of sensitivity, speed and specificity. Dihydrocodeine and heroin can also be assayed. The method is based on extraction of the opiates from serum, plasma and cerebrospinal fluid using reversed-phase solid-phase extraction columns, followed by reversed-phase high-performance liquid chromatography with native fluorescence detection. The extraction step provides greater than 95% recovery, and the response of the detection system is linear from 0.5 to beyond 750 ng. The method allows analysis of M, NM, M3G, M6G and C. No other drugs have been found to interfere with the assay. The assay offers a quick, cheap and reliable method of specifically determining morphine and its metabolites, including the potent M6G, from a small sample volume; this will be of advantage to both clinician and basic scientist.

摘要

相似文献

1
Fast reliable assay for morphine and its metabolites using high-performance liquid chromatography and native fluorescence detection.
J Chromatogr. 1990 Feb 23;525(2):379-88. doi: 10.1016/s0378-4347(00)83414-3.
2
Quantitation of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in plasma and cerebrospinal fluid using solid-phase extraction and high-performance liquid chromatography with electrochemical detection.采用固相萃取和高效液相色谱-电化学检测法对血浆和脑脊液中的吗啡、吗啡-3-葡萄糖醛酸苷和吗啡-6-葡萄糖醛酸苷进行定量分析。
Ther Drug Monit. 1994 Apr;16(2):200-8. doi: 10.1097/00007691-199404000-00016.
3
Determination of morphine and codeine in plasma by HPLC following solid phase extraction.固相萃取后用高效液相色谱法测定血浆中的吗啡和可待因
J Pharm Biomed Anal. 1997 Mar;15(6):759-64. doi: 10.1016/s0731-7085(96)01911-5.
4
High-performance liquid chromatographic determination of morphine, morphine-3-glucuronide, morphine-6-glucuronide and codeine in biological samples using multi-wavelength forward optical detection.使用多波长正向光学检测法通过高效液相色谱法测定生物样品中的吗啡、吗啡 - 3 - 葡萄糖醛酸苷、吗啡 - 6 - 葡萄糖醛酸苷和可待因。
J Chromatogr. 1991 Nov 15;571(1-2):263-70. doi: 10.1016/0378-4347(91)80454-k.
5
Morphine and morphine glucuronides in serum of heroin consumers and in heroin-related deaths determined by HPLC with native fluorescence detection.
J Anal Toxicol. 1995 May-Jun;19(3):163-8. doi: 10.1093/jat/19.3.163.
6
Rapid and highly automated determination of morphine and morphine glucuronides in plasma by on-line solid-phase extraction and column liquid chromatography.通过在线固相萃取和柱液相色谱法快速、高度自动化测定血浆中的吗啡和吗啡葡糖醛酸化物。
J Chromatogr B Biomed Appl. 1995 Dec 1;674(1):57-63. doi: 10.1016/0378-4347(95)00295-7.
7
Morphine, morphine-3-glucuronide, morphine-6-glucuronide, and 6-monoacetylmorphine determined by means of atmospheric pressure chemical ionization-mass spectrometry-liquid chromatography in body fluids of heroin victims.通过大气压化学电离质谱-液相色谱法测定海洛因受害者体液中的吗啡、吗啡-3-葡萄糖醛酸苷、吗啡-6-葡萄糖醛酸苷和6-单乙酰吗啡。
J Anal Toxicol. 1997 Sep;21(5):346-55. doi: 10.1093/jat/21.5.346.
8
Determination of morphine and its 3- and 6-glucuronides, codeine, codeine-glucuronide and 6-monoacetylmorphine in body fluids by liquid chromatography atmospheric pressure chemical ionization mass spectrometry.采用液相色谱-大气压化学电离质谱法测定体液中的吗啡及其3-和6-葡萄糖醛酸苷、可待因、可待因-葡萄糖醛酸苷和6-单乙酰吗啡。
J Chromatogr B Biomed Sci Appl. 1997 Dec 5;703(1-2):115-27. doi: 10.1016/s0378-4347(97)00384-8.
9
A highly sensitive assay for the simultaneous determination of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in human plasma by high-performance liquid chromatography with electrochemical and fluorescence detection.一种通过高效液相色谱结合电化学和荧光检测同时测定人血浆中吗啡、吗啡-3-葡萄糖醛酸苷和吗啡-6-葡萄糖醛酸苷的高灵敏度检测方法。
Ther Drug Monit. 1996 Apr;18(2):179-88. doi: 10.1097/00007691-199604000-00012.
10
A simple, rapid method for the simultaneous determination of morphine and its principal metabolites in plasma using high-performance liquid chromatography and fluorometric detection.
Ther Drug Monit. 1991 May;13(3):226-32. doi: 10.1097/00007691-199105000-00007.

引用本文的文献

1
Rapid analysis of intraperitoneally administered morphine in mouse plasma and brain by microchip electrophoresis-electrochemical detection.微芯片电泳-电化学检测法快速分析腹腔内给予的吗啡在小鼠血浆和脑中的分布。
Sci Rep. 2019 Mar 1;9(1):3311. doi: 10.1038/s41598-019-40116-5.
2
Different distribution of morphine and morphine-6 beta-glucuronide after intracerebroventricular injection in rats.大鼠脑室内注射后吗啡和吗啡-6β-葡萄糖醛酸苷的不同分布
Br J Pharmacol. 2003 Sep;140(1):211-7. doi: 10.1038/sj.bjp.0705418. Epub 2003 Aug 4.
3
Morphine antinociception is enhanced in mdr1a gene-deficient mice.
多药耐药蛋白1a(mdr1a)基因缺陷型小鼠的吗啡镇痛作用增强。
Pharm Res. 2000 Jun;17(6):749-53. doi: 10.1023/a:1007546719287.
4
Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat.强效P-糖蛋白抑制剂GF120918对大鼠吗啡药代动力学和药效学的影响。
Pharm Res. 1998 Apr;15(4):599-605. doi: 10.1023/a:1011938112599.
5
A pharmacokinetic-pharmacodynamic model of tolerance to morphine analgesia during infusion in rats.大鼠输注过程中对吗啡镇痛耐受性的药代动力学-药效学模型。
J Pharmacokinet Biopharm. 1995 Dec;23(6):531-49. doi: 10.1007/BF02353460.
6
Morphine metabolism in neonates and infants.新生儿和婴儿的吗啡代谢
Br J Clin Pharmacol. 1992 Nov;34(5):434-7. doi: 10.1111/j.1365-2125.1992.tb05652.x.
7
Evidence for analgesia mediated by peripheral opioid receptors in inflamed synovial tissue.炎症滑膜组织中由外周阿片受体介导的镇痛作用的证据。
Eur J Clin Pharmacol. 1992;43(4):351-5. doi: 10.1007/BF02220608.